Health Canada
- Status: approved
🇨🇦 Mometasone furoate 220 in Canada
Mometasone furoate 220 (Mometasone furoate 220) regulatory status in Canada.
Marketing authorisation
Mometasone furoate 220 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Mometasone furoate 220 approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Mometasone furoate 220 in Canada?
California Allergy and Asthma Medical Group, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.